The Gout Therapeutic Market is expanding as the prevalence of gout and other uric acid-related disorders continues to create demand for effective treatment options. Greater awareness of disease symptoms and long-term complications is encouraging patients to seek timely medical care. The Gout Therapeutic Market was valued at US$ 3.06 Billion in 2025 and is expected to reach US$ 5.19 Billion by...